Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Arginine Supplementation to Improve Cardiovascular and Endothelial Function After NSAID Treatment (ASCENT)

NCT04765644 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT04765644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04765644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Arginine Supplementation to Improve Cardiovascular and Endothelial Function After NSAID Treatment (ASCENT)
Lead sponsor
Imperial College London
Phase
Phase 4
Overall status
Completed
Start date
June 10, 2021
Completion date
January 24, 2022
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy